サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1459464

迅速微生物検査の世界市場：製品 (機器・試薬・キット)・手法・用途別 - 予測（～2029年）

Rapid Microbiology Testing Market by Product (Instruments Reagent, Kits), Method, Application - Global Forecast to 2029
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 318 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
迅速微生物検査の世界市場：製品 (機器・試薬・キット)・手法・用途別 - 予測（～2029年）
出版日: 2024年04月01日
発行: MarketsandMarkets
ページ情報: 英文 318 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の迅速微生物検査の市場規模は、予測期間中に10.1%のCAGRで推移し、2024年の52億米ドルから、2029年には83億米ドルの規模に成長すると予測されています。

近年のより新しく高速な技術の導入より、従来の微生物検査から迅速検査法への移行が徐々に進んでいます。これらの技術は、細菌の生物学的増幅の必要性を排除し、検出をより迅速かつ効率的にします。微生物検査は、従来の検査法に伴う長い所要時間や病原性菌株への暴露という制限を克服しています。有効性、効率性、正確性、結果の迅速化、機能性の向上といった継続的なR&Dにより、微生物検査における技術的進歩は、臨床ラボ、病院、学術機関、研究ラボ、製薬・バイオ技術企業の関心を高めています。

調査範囲
調査対象年 2022-2029年
基準年 2023年
予測期間 2024-2029年
単位 金額 (米ドル)
セグメント 製品・手法・用途
対象地域 北米・欧州・アジア太平洋・ラテンアメリカ・中東&アフリカ・GCC諸国

製品別では、試薬・キットの部門が予測期間中にもっとも高い成長率を示す見通しです。同部門の成長を促進する主な要因には、実施される感染症診断検査数の増加、幅広い試薬への容易なアクセス、より信頼性が高く、より特異的で、より迅速な微生物の初期段階での検出に対するニーズの高まりなどがあります。

手法別では、核酸ベースの部門が予測期間中にもっとも高い成長率を示す見通しです。同部門の急成長は、技術的進歩、より高い精度、カスタマイズ機能の組み合わせによってもたらされます。

地域別では、アジア太平洋地域がもっとも急成長している地域です。この地域の新興国は、可処分所得水準の顕著な増加とともに国内総生産 (GDP) が上昇しています。その結果、より多くの人々の間で医療支出が急増しています。この動向は、患者人口の多さと、同地域におｋる多数の低価格機器メーカーの存在に起因しています。

当レポートでは、世界の迅速微生物検査の市場を調査し、市場概要、市場影響因子および市場機会の分析、技術・特許の動向、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 貿易分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制状況
  • 技術分析
  • 主な会議とイベント
  • 顧客のビジネスに影響を与える動向/ディスラプション
  • 主なステークホルダーと購入基準
  • 投資と資金調達のシナリオ

第6章 迅速微生物検査市場：製品別

  • 機器
    • 自動微生物識別および抗菌薬感受性試験システム
    • 質量分析計
    • 生物発光および蛍光ベースの検出システム
    • PCRシステム
    • サイトメーター
    • アクティブエアサンプラー
    • その他
  • 試薬・キット
    • 滅菌試薬・キット
    • その他の試薬・キット
  • 消耗品

第7章 迅速微生物検査市場：手法別

  • 増殖ベースの迅速微生物検査
  • 細胞成分ベースの迅速微生物検査
  • 核酸ベースの迅速微生物検査
  • 生存率ベースの迅速微生物検査
  • その他

第8章 迅速微生物検査市場：用途別

  • 産業試験
    • 食品・飲料検査
    • 医薬品・生物製剤検査
    • 環境試験
    • 化粧品・パーソナルケア製品検査
    • その他
  • 臨床疾患診断
  • 研究

第9章 迅速微生物検査市場：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
  • GCC諸国

第10章 競合情勢

  • 主要企業の採用アプローチ
  • 収益分配分析
  • 市場シェア分析
  • 企業評価マトリックス：主要企業
  • 企業評価マトリックス：スタートアップ/中小企業
  • 迅速微生物検査ベンダーの評価と財務指標
  • ブランド/製品比較分析
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • BIOMERIEUX SA
    • BECTON, DICKINSON AND COMPANY
    • DANAHER CORPORATION
    • ABBOTT LABORATORIES
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • BRUKER
    • QUIDELORTHO CORPORATION
    • SARTORIUS AG
    • CHARLES RIVER LABORATORIES
    • NEOGEN CORPORATION
  • その他の企業
    • DON WHITLEY SCIENTIFIC LIMITED
    • RAPID MICRO BIOSYSTEMS, INC.
    • GRADIENTECH
    • PERKINELMER INC.
    • RQMICRO AG
    • COLIFAST AS
    • SEROSEP LIMITED
    • BTNX INC.
    • R-BIOPHARM AG
    • PARAGON GENOMICS, INC.
    • KYPHA INC.
    • VIVIONE BIOSCIENCES
    • BACTEST LTD.
    • CORDX

第12章 付録

目次
Product Code: MD 6602

The rapid microbiology testing market is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period. There has been a gradual shift from traditional microbiology testing to rapid testing methods in recent years due to the introduction of newer and faster technologies. These technologies eliminate the need for biological amplification of bacteria, making detection quicker and more efficient. Microbial testing has overcome the limitations of long procedural times and exposure to pathogenic strains associated with conventional testing methods. With continuous developments in efficacy, efficiency, accuracy, faster results, and improved functionality, technological advancements in microbiology testing have generated increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical & biotechnology companies.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct, method, and application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

"Reagents & kits segment accounted for the highest growth rate in the rapid microbiology testing market, by product, during the forecast period."

The rapid microbiology testing market is bifurcated into instruments, reagents & kits, and consumables. The reagents & kits segment in the rapid microbiology testing market is experiencing substantial growth. Major factors driving the growth of this segment include the increasing number of infectious disease diagnostic tests carried out, easy accessibility to a wide range of reagents, and the growing need for more reliable, more specific, and faster detection of microbes in the early stages.

"Nucleic acid-based rapid microbiology testing segment accounted for the highest growth rate in the rapid microbiology testing market, by method, during the forecast period."

The rapid microbiology testing market is bifurcated into growth-based, cellular component-based, nucleic acid-based, viability-based, and other rapid microbiology testing methods based on method. Nucleic acid-based rapid microbiology testing segment is expected to account for the highest CAGR during the forecast period. The rapid growth of this segment is driven by a combination of technological advancements, greater accuracy, and customization capabilities.

"Asia Pacific: The fastest-growing region rapid microbiology testing market."

The worldwide market for rapid microbiology testing is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Emerging economies in this geographical area are observing an upswing in their gross domestic products (GDPs) along with a noteworthy increase in disposable income levels. Consequently, there has been a surge in healthcare expenditure among a larger segment of the population. This trend can be attributed to the sizable patient population and the presence of numerous low-cost device manufacturers in the region.

The break-up of the profile of primary participants in the rapid microbiology testing market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in rapid microbiology testing market are bioMerieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland), Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and CorDx (US).

Research Coverage:

This research report categorizes the rapid microbiology testing market by product (Instruments (automated microbial identification & antimicrobial susceptibility testing systems, mass spectrometers, PCR systems, bioluminescence & fluorescence-based detection systems, cytometers, active air samplers, other instruments), reagents & kits (sterility testing reagents & kits and other reagents & kits), and consumables), by method (Growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing, and other rapid microbiology testing methods), by application (Clinical disease diagnosis, industrial testing (food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing, and other industrial testing applications), and research applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the rapid microbiology testing market. Competitive analysis of upcoming startups in the rapid microbiology testing market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall rapid microbiology testing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing incidence of infectious diseases and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and Increased focus on early detection of infectious diseases), opportunities (Growth opportunities in emerging countries), restraints (High capital investments and low cost-benefit ratio and nfavorable regulatory and reimbursement scenario), and challenges (Operational barriers) influencing the growth of the rapid microbiology testing market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the rapid microbiology testing market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the rapid microbiology testing market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like bioMerieux SA (France), Becton, Dickinson and Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS
  • 1.4 STUDY SCOPE
    • 1.4.1 RAPID MICROBIOLOGY TESTING MARKET
    • 1.4.2 REGIONS COVERED
    • 1.4.3 YEARS CONSIDERED
    • 1.4.4 CURRENCY CONSIDERED
  • 1.5 RESEARCH LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 RISK ASSESSMENT: RAPID MICROBIOLOGY TESTING MARKET
  • 2.9 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 8 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 9 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
    • FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
    • FIGURE 12 GROWING FOCUS ON EARLY DETECTION OF DISEASES TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
  • 4.2 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.3 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • 4.4 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 15 INDUSTRIAL TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RAPID MICROBIOLOGY TESTING MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of infectious diseases and cancer
    • TABLE 1 ESTIMATED NUMBER OF NEW CANCER CASES FOR BOTH GENDERS (AGE: 0-85+), 2022 VS. 2045
      • 5.2.1.2 Technological advancements in rapid microbiology testing
      • 5.2.1.3 Increased funding for R&D
      • 5.2.1.4 Increased focus on early detection of infectious diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital investments and low cost-benefit ratio
      • 5.2.2.2 Unfavorable regulatory and reimbursement scenario
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Operational barriers
  • 5.3 PRICING ANALYSIS
    • TABLE 2 INDICATIVE PRICING FOR RAPID MICROBIOLOGY TESTING PRODUCTS
    • TABLE 3 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION
  • 5.4 PATENT ANALYSIS
    • FIGURE 18 PATENT ANALYSIS FOR PCR SYSTEMS (JANUARY 2014-DECEMBER 2023)
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS OF RAPID MICROBIOLOGY TESTING MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    • TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 5 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 21 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
    • 5.8.1 RAPID MICROBIOLOGY TESTING MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 RAPID MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2 NORTH AMERICA
      • 5.10.2.1 US
      • 5.10.2.2 Canada
    • 5.10.3 EUROPE
    • TABLE 11 EUROPE: CLASSIFICATION OF DEVICES
    • 5.10.4 ASIA PACIFIC
      • 5.10.4.1 China
      • 5.10.4.2 Japan
    • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.10.4.3 India
    • 5.10.5 LATIN AMERICA
      • 5.10.5.1 Brazil
      • 5.10.5.2 Mexico
    • 5.10.6 MIDDLE EAST
      • 5.10.6.1 Africa
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Automated multiplex PCR systems
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Optical immunosensors
      • 5.11.2.2 Electrochemical immunosensors
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 MALDI-TOF mass spectrometry
  • 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
    • TABLE 13 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR RAPID MICROBIOLOGY TESTING MARKET
    • 5.13.2 REVENUE SHIFT IN RAPID MICROBIOLOGY TESTING MARKET
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS
    • TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS (%)
    • 5.14.2 BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
    • TABLE 15 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • 5.15 INVESTMENT & FUNDING SCENARIO
    • FIGURE 24 RAPID MICROBIOLOGY TESTING MARKET: INVESTMENT & FUNDING SCENARIO

6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 16 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 6.2 INSTRUMENTS
    • TABLE 17 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET
    • TABLE 18 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 19 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 20 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 21 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 23 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
      • 6.2.1.1 Ease of use compared to conventional identification processes to support market growth
    • TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 26 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 28 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2 MASS SPECTROMETERS
      • 6.2.2.1 Rapid results associated with mass spectrometry methods to boost adoption
    • TABLE 29 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 30 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 31 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 33 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
      • 6.2.3.1 Unwanted detection of non-microbial ATP to limit market adoption
    • TABLE 34 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 35 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 36 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 38 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4 PCR SYSTEMS
      • 6.2.4.1 Growing use of standard PCR, real-time PCR, and qPCR for rapid microbial testing to support growth
    • TABLE 39 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 40 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 41 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 43 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.5 CYTOMETERS
      • 6.2.5.1 Ability to detect viable organisms to favor market growth
    • TABLE 44 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 45 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 46 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 48 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.6 ACTIVE AIR SAMPLERS
      • 6.2.6.1 Convenience and ease of use to drive demand for active air samplers
    • TABLE 49 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 50 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 51 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 53 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.7 OTHER INSTRUMENTS
    • TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 55 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 56 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 58 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 REAGENTS & KITS
    • TABLE 59 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 60 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 61 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 64 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1 STERILITY REAGENTS & KITS
      • 6.3.1.1 Increasing adoption of BET assays to propel market growth
    • TABLE 65 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 66 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 69 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.2 OTHER REAGENTS & KITS
    • TABLE 70 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 72 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 74 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4 CONSUMABLES
    • 6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
    • TABLE 75 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 76 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 77 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 79 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD

  • 7.1 INTRODUCTION
    • TABLE 80 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 81 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
  • 7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
    • 7.2.1 GROWING DEMAND FOR GROWTH-BASED RAPID MICROBIOLOGY TESTING TO DRIVE MARKET GROWTH
    • TABLE 82 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 83 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 86 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
    • 7.3.1 HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY ASSOCIATED WITH THIS METHOD TO BOOST MARKET
    • TABLE 87 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
    • 7.4.1 HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
    • TABLE 92 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 93 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 94 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
    • 7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
    • TABLE 97 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 98 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 99 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 101 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
    • TABLE 102 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 103 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 104 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 106 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 8.1.1 PRIMARY NOTES
      • 8.1.1.1 Key industry insights
  • 8.2 INDUSTRIAL TESTING
    • TABLE 108 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 109 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 110 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 111 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 113 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.1 FOOD & BEVERAGE TESTING
      • 8.2.1.1 Stringent quality control and quality assurance processes to drive market growth
    • TABLE 114 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 115 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 116 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 118 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
      • 8.2.2.1 Improved regulatory scenario for drug development to support market growth
    • TABLE 119 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 121 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.3 ENVIRONMENTAL TESTING
      • 8.2.3.1 Growing focus on environmental monitoring to boost segmental growth
    • TABLE 124 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 125 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 126 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 128 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.4 COSMETICS & PERSONAL CARE PRODUCTS TESTING
      • 8.2.4.1 Growing use of rapid microbiology testing in these industries to determine presence of microbes to favor market growth
    • TABLE 129 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 130 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 131 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS
    • TABLE 134 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 135 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 136 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 138 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 CLINICAL DISEASE DIAGNOSIS
    • 8.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
    • TABLE 139 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 140 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 143 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 RESEARCH APPLICATIONS
    • 8.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH
    • TABLE 144 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 145 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 146 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 148 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 149 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
    • TABLE 150 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 151 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 152 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 155 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • 9.2.2 US
      • 9.2.2.1 Increasing adoption of technologically advanced products in US to favor market growth
    • TABLE 156 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 157 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 159 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 160 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Favorable environment for R&D and rising incidence of infectious diseases to drive market
    • TABLE 161 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 162 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 163 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 164 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 165 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 166 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 167 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 169 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 170 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 171 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.1 EUROPE: RECESSION IMPACT
    • 9.3.2 GERMANY
      • 9.3.2.1 Rising emphasis on food testing and safety to fuel market growth
    • TABLE 172 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 173 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 174 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 175 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 176 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing investments and funding by government to drive market growth
    • TABLE 177 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 178 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 179 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 180 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 181 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Rising R&D expenditure to favor market growth
    • TABLE 182 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 183 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 184 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 185 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 186 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market
    • TABLE 187 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 188 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 189 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 190 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 191 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising geriatric population and improving healthcare infrastructure to boost market growth
    • TABLE 192 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 193 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 194 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 195 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 196 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.7 RUSSIA
      • 9.3.7.1 Increasing access to quality healthcare to propel market growth
    • TABLE 197 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 198 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 199 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 200 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 201 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.3.8 REST OF EUROPE
    • TABLE 202 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 203 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 204 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 205 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 206 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
    • TABLE 207 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 9.4.2 CHINA
      • 9.4.2.1 Rising importance of quality control across food and pharmaceutical industries to drive market growth
    • TABLE 213 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 214 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 217 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising geriatric population in Japan to support market growth
    • TABLE 218 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 219 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 220 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 221 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 222 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing private and public investments in healthcare systems to drive adoption of rapid microbiology testing products
    • TABLE 223 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 224 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 225 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 226 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 227 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing awareness about antimicrobial resistance to fuel market
    • TABLE 228 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 229 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 230 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 231 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 232 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC
    • TABLE 233 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 234 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 235 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 236 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 237 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 238 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 239 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 240 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 241 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 242 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 243 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • 9.5.2 BRAZIL
      • 9.5.2.1 Improving healthcare infrastructure and stringent regulations to fuel market
    • TABLE 244 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 245 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 247 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 248 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Improving accessibility and affordability of healthcare services to support market growth
    • TABLE 249 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 250 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 251 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 252 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 253 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 254 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 255 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 256 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 257 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 258 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
    • TABLE 259 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 260 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 261 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 262 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 263 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 9.7 GCC COUNTRIES
    • 9.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 264 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 265 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 266 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 267 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
    • TABLE 268 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 9.7.2 GCC COUNTRIES: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET
    • TABLE 269 RAPID MICROBIOLOGY TESTING MARKET: STRATEGIES ADOPTED
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS (2018-2022)
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 RAPID MICROBIOLOGY TESTING MARKET
    • FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
    • TABLE 270 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
    • 10.5.6 COMPANY FOOTPRINT
    • FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT
    • TABLE 271 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT
    • TABLE 272 RAPID MICROBIOLOGY TESTING MARKET: REGIONAL FOOTPRINT
    • TABLE 273 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
    • 10.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
    • TABLE 274 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • 10.7 VALUATION AND FINANCIAL METRICS OF RAPID MICROBIOLOGY TESTING VENDORS
    • FIGURE 32 EV/EBITDA OF KEY VENDORS
    • FIGURE 33 P/E RATIO OF KEY VENDORS
  • 10.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • FIGURE 34 PRODUCT/BRAND COMPARISON: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING PRODUCTS
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • TABLE 275 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2020-JANUARY 2024
    • 10.9.2 DEALS
    • TABLE 276 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2020-JANUARY 2024
    • 10.9.3 EXPANSIONS
    • TABLE 277 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2020-JANUARY 2024

11 COMPANY PROFILES

  • (Business overview, Products offered, Recent Developments, MNM view)**
  • 11.1 KEY PLAYERS
    • 11.1.1 BIOMERIEUX SA
    • TABLE 278 BIOMERIEUX SA: COMPANY OVERVIEW
    • FIGURE 35 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
    • TABLE 279 BIOMERIEUX SA: PRODUCTS OFFERED
    • TABLE 280 BIOMERIEUX SA: PRODUCT LAUNCHES & APPROVALS
    • TABLE 281 BIOMERIEUX SA: DEALS
    • TABLE 282 BIOMERIEUX SA: OTHER DEVELOPMENTS
    • 11.1.2 BECTON, DICKINSON AND COMPANY
    • TABLE 283 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
    • TABLE 284 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
    • TABLE 285 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS
    • TABLE 286 BECTON, DICKINSON AND COMPANY: DEALS
    • 11.1.3 DANAHER CORPORATION
    • TABLE 287 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 288 DANAHER CORPORATION: PRODUCTS OFFERED
    • TABLE 289 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 290 DANAHER CORPORATION: DEALS
    • TABLE 291 DANAHER CORPORATION: EXPANSIONS
    • 11.1.4 ABBOTT LABORATORIES
    • TABLE 292 ABBOTT LABORATORIES: COMPANY OVERVIEW
    • FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
    • TABLE 293 ABBOTT LABORATORIES: PRODUCTS OFFERED
    • TABLE 294 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
    • 11.1.5 THERMO FISHER SCIENTIFIC INC.
    • TABLE 295 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
    • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • TABLE 296 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
    • TABLE 297 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
    • TABLE 298 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 11.1.6 MERCK KGAA
    • TABLE 299 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • TABLE 300 MERCK KGAA: PRODUCTS OFFERED
    • TABLE 301 MERCK KGAA: DEALS
    • 11.1.7 BRUKER
    • TABLE 302 BRUKER: COMPANY OVERVIEW
    • FIGURE 41 BRUKER: COMPANY SNAPSHOT (2022)
    • TABLE 303 BRUKER: PRODUCTS OFFERED
    • TABLE 304 BRUKER: PRODUCT LAUNCHES
    • 11.1.8 QUIDELORTHO CORPORATION
    • TABLE 305 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
    • FIGURE 42 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 306 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
    • TABLE 307 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 308 QUIDELORTHO CORPORATION: DEALS
    • TABLE 309 QUIDELORTHO CORPORATION: OTHER DEVELOPMENTS
    • 11.1.9 SARTORIUS AG
    • TABLE 310 SARTORIUS AG: COMPANY OVERVIEW
    • FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2023)
    • TABLE 311 SARTORIUS AG: PRODUCTS OFFERED
    • 11.1.10 CHARLES RIVER LABORATORIES
    • TABLE 312 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
    • FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
    • TABLE 313 CHARLES RIVER LABORATORIES: PRODUCTS OFFERED
    • TABLE 314 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES
    • TABLE 315 CHARLES RIVER LABORATORIES: DEALS
    • 11.1.11 NEOGEN CORPORATION
    • TABLE 316 NEOGEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 45 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 317 NEOGEN CORPORATION: PRODUCTS OFFERED
    • TABLE 318 NEOGEN CORPORATION: PRODUCT LAUNCHES
  • *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 DON WHITLEY SCIENTIFIC LIMITED
    • 11.2.2 RAPID MICRO BIOSYSTEMS, INC.
    • 11.2.3 GRADIENTECH
    • 11.2.4 PERKINELMER INC.
    • 11.2.5 RQMICRO AG
    • 11.2.6 COLIFAST AS
    • 11.2.7 SEROSEP LIMITED
    • 11.2.8 BTNX INC.
    • 11.2.9 R-BIOPHARM AG
    • 11.2.10 PARAGON GENOMICS, INC.
    • 11.2.11 KYPHA INC.
    • 11.2.12 VIVIONE BIOSCIENCES
    • 11.2.13 BACTEST LTD.
    • 11.2.14 CORDX

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS